SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178879-21-000013
Filing Date
2021-11-09
Accepted
2021-11-09 16:10:45
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fold-20210930.htm   iXBRL 10-Q 1460139
2 EX-10.9 fold-09302021xex109.htm EX-10.9 16675
3 EX-31.1 fold-09302021xex311.htm EX-31.1 11157
4 EX-31.2 fold-09302021xex312.htm EX-31.2 11234
5 EX-32.1 fold-09302021xex321.htm EX-32.1 8594
  Complete submission text file 0001178879-21-000013.txt   6542822

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20210930.xsd EX-101.SCH 31969
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20210930_cal.xml EX-101.CAL 76504
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20210930_def.xml EX-101.DEF 183195
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20210930_lab.xml EX-101.LAB 518614
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20210930_pre.xml EX-101.PRE 351982
11 EXTRACTED XBRL INSTANCE DOCUMENT fold-20210930_htm.xml XML 1158399
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 211392222
SIC: 2834 Pharmaceutical Preparations